The healthcare group is currently valued low on the stock exchange.
(Photo: Fresenius)
Frankfurt Fresenius shareholders have had few friends with their investment in recent months. The group has already hit the profit target twice this year, and the share fell to an eleven-year low in October.
The expectations of the new CEO Michael Sen, who has been in office since October, are all the greater: he must ensure that the Dax group grows more profitably, reduce the high debt and increase the value of the company. Good news could also support the stock’s uptrend in the short term.
The group could also achieve a higher rating if it changes its structure. Since the latest profit warnings from Fresenius were mainly due to problems at the dialysis subsidiary Fresenius Medical Care (FMC), investors had recently increasingly called for FMC to be spun off from the parent company.
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Continue
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Continue